The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Distinct but complementary contributions of PPAR isotypes to energy homeostasis
Open accessAbstract
Peroxisome proliferator-activated receptors (PPARs) regulate energy metabolism and hence are therapeutic targets in metabolic diseases such as type 2 diabetes and non-alcoholic fatty liver disease. While they share anti-inflammatory activities, the PPAR isotypes distinguish themselves by differential actions on lipid and glucose homeostasis. In this Review we discuss the complementary and distinct metabolic effects of the PPAR isotypes together with the underlying cellular and molecular mechanisms, as well as the synthetic PPAR ligands that are used in the clinic or under development. We highlight the potential of new PPAR ligands with improved efficacy and safety profiles in the treatment of complex metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Stechschulte, L. A., Ge, C., Hinds, T. D., Sánchez, E. R., Franceschi, R. T., & Lecka‐Czernik, B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752493 · Cited by 24
RetractedHeinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439 · cited 2×
“Fibrate outcome trials such as the Helsinki Heart Study (HHS) (15), Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (VA-HIT) (16), Bezaf-ibrate Infarction Prevention (BIP) (17), Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) (18), and Action to Control Cardiovascular Risk in D…”
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837 · cited 7×
“Several fibrate trials, including FIELD and ACCORD, failed to meet the primary endpoint of reduced CV risk; however, such negative outcomes are likely linked to inappropriate patient selection, since subgroup analyzes revealed significant CV risk reduction in those patients with marked dyslipid-emia upon trial enrolme…”
InfluentialA genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Hatori, M., Vollmers, C., Zarrinpar, A., DiTacchio, L., Bushong, E. A., Gill, S., Leblanc, M., Chaix, A., Joens, M., Fitzpatrick, J. A. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.019 · Cited by 1,986
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Pawlak, M., Lefebvre, P., & Staels, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.039 · Cited by 1,578
Self-citationMetabolic syndrome: a closer look at the growing epidemic and its associated pathologies
O'Neill, S., & O'Driscoll, L. (2015) · Obesity Reviews · doi:10.1111/obr.12229 · Cited by 1,547
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Home, P. D., Pocock, S. J., Beck-Nielsen, H., Curtis, P. S., Gomis, R., Hanefeld, M., Jones, N. P., Komajda, M., & McMurray, J. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60953-3 · Cited by 1,393
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368
Manninen, V, Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., & Frick, M. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.37 · Cited by 1,329
Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
Self-citationPeroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Schoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173
Self-citationPPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C., & Mathis, D. (2012) · Nature · doi:10.1038/nature11132 · Cited by 1,143
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
Kernan, W. N., Viscoli, C. M., Furie, K. L., Young, L. H., Inzucchi, S. E., Gorman, M., Guarino, P. D., Lovejoy, A. M., Peduzzi, P. N., Conwit, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506930 · Cited by 1,124
Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089
Self-citationLoss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
The TG and HDL Working Group of the Exome Sequencing Project, N. H. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1307095 · Cited by 1,071
Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodríguez de Fonseca, F., Rosengarth, A., Luecke, H., Di Giacomo, B., Tarzia, G., et al. (2003) · Nature · doi:10.1038/nature01921 · Cited by 1,064
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Self-citationTFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop
Settembre, C., De Cegli, R., Mansueto, G., Saha, P. K., Vetrini, F., Visvikis, O., Huynh, T., Carissimo, A., Palmer, D., Jürgen Klisch, T., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2718 · Cited by 1,022
Nuclear Receptor Expression Links the Circadian Clock to Metabolism
Yang, X., Downes, M., Yu, R. T., Bookout, A. L., He, W., Straume, M., Mangelsdorf, D. J., & Evans, R. M. (2006) · Cell · doi:10.1016/j.cell.2006.06.050 · Cited by 934
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
Jun, M., Foote, C., Lv, J., Neal, B., Patel, A., Nicholls, S. J., Grobbee, D. E., Cass, A., Chalmers, J., & Perkovic, V. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60656-3 · Cited by 927
Zhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z.-G., Liu, F., Wong, R. L. C., Chow, W.-S., Tso, A. W. K., Lam, K. S. L., et al. (2008) · Diabetes · doi:10.2337/db07-1476 · Cited by 908
PPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
Akune, T., Ohba, S., Kamekura, S., Yamaguchi, M., Chung, U.-I., Kubota, N., Terauchi, Y., Harada, Y., Azuma, Y., Nakamura, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19900 · Cited by 869
Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Red Eagle, A., Vats, D., Morel, C. R., Goforth, M. H., Subramanian, V., Mukundan, L., Ferrante, A. W., & Chawla, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.003 · Cited by 847
Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306981100 · Cited by 832
PPARs in Obesity-Induced T2DM, Dyslipidaemia and NAFLD
Gross, B., Pawlak, M., Lefebvre, P., & Staels, B. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.135 · Cited by 778
Self-citationATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
Haemmerle, G., Moustafa, T., Woelkart, G., Büttner, S., Schmidt, A., van de Weijer, T., Hesselink, M., Jaeger, D., Kienesberger, P. C., Zierler, K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2439 · Cited by 761
The randle cycle revisited: a new head for an old hat.
Hue, L., & Taegtmeyer, H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00093.2009 · Cited by 743
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Montagner, A., Polizzi, A., Fouché, E., Ducheix, S., Lippi, Y., Lasserre, F., Barquissau, V., Régnier, M., Lukowicz, C., Benhamed, F., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310798 · Cited by 736
Yu, J. G., Javorschi, S., Hevener, A. L., Kruszynska, Y. T., Norman, R. A., Sinha, M., & Olefsky, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2968 · Cited by 725
Reprogramming of the Circadian Clock by Nutritional Challenge
Eckel-Mahan, K. L., Patel, V. R., de Mateo, S., Orozco-Solis, R., Ceglia, N. J., Sahar, S., Dilag-Penilla, S. A., Dyar, K. A., Baldi, P., & Sassone-Corsi, P. (2013) · Cell · doi:10.1016/j.cell.2013.11.034 · Cited by 723
Kang, K., Reilly, S. M., Karabacak, V., Gangl, M. R., Fitzgerald, K., Hatano, B., & Lee, C.-H. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.002 · Cited by 699
Integrated physiology and systems biology of PPARα
Kersten, S. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.002 · Cited by 670
mTORC1 controls fasting-induced ketogenesis and its modulation by ageing
Sengupta, S., Peterson, T. R., Laplante, M., Oh, S., & Sabatini, D. M. (2010) · Nature · doi:10.1038/nature09584 · Cited by 646
Ratziu, V., Giral, P., Jacqueminet, S., Charlotte, F., Hartemann–Heurtier, A., Serfaty, L., Podevin, P., Lacorte, J., Bernhardt, C., Bruckert, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.078 · Cited by 625
PPARγ and the global map of adipogenesis and beyond
Lefterova, M. I., Haakonsson, A. K., Lazar, M. A., & Mandrup, S. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.04.001 · Cited by 623
Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock
Liang, X., Bushman, F. D., & FitzGerald, G. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501305112 · Cited by 578
Scott, R., O'Brien, R., Fulcher, G., Pardy, C., d'Emden, M., Tse, D., Taskinen, M.-R., Ehnholm, C., Keech, A., & on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators (2009) · Diabetes Care · doi:10.2337/dc08-1543 · Cited by 551
“New” hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis
Chakravarthy, M. V., Pan, Z., Zhu, Y., Tordjman, K., Schneider, J. G., Coleman, T., Turk, J., & Semenkovich, C. F. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.04.002 · Cited by 545
Dutchak, P. A., Katafuchi, T., Bookout, A. L., Choi, J. H., Yu, R. T., Mangelsdorf, D. J., & Kliewer, S. A. (2012) · Cell · doi:10.1016/j.cell.2011.11.062 · Cited by 537
Dongiovanni, P., Petta, S., Maglio, C., Fracanzani, A. L., Pipitone, R., Mozzi, E., Motta, B. M., Kaminska, D., Rametta, R., Grimaudo, S., et al. (2015) · Hepatology · doi:10.1002/hep.27490 · Cited by 533 · cited 1×
“org Volume 127 Number 4 April 2017 (67), an effect not observed in PPARα agonist–treated patients (68).”
Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver
Chakravarthy, M. V., Lodhi, I. J., Yin, L., Malapaka, R. R. V., Xu, H. E., Turk, J., & Semenkovich, C. F. (2009) · Cell · doi:10.1016/j.cell.2009.05.036 · Cited by 533
PPAR-γ regulates osteoclastogenesis in mice
Wan, Y., Chong, L.-W., & Evans, R. M. (2007) · Nature Medicine · doi:10.1038/nm1672 · Cited by 517
Peroxisome proliferator‐activated receptor δ controls muscle development and oxydative capability
Luquet, S., Lopez‐Soriano, J., Holst, D., Fredenrich, A., Melki, J., Rassoulzadegan, M., & Grimaldi, P. A. (2003) · The FASEB Journal · doi:10.1096/fj.03-0269fje · Cited by 509
PPARδ regulates glucose metabolism and insulin sensitivity
Lee, C.-H., Olson, P., Hevener, A., Mehl, I., Chong, L.-W., Olefsky, J. M., Gonzalez, F. J., Ham, J., Kang, H., Peters, J. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511253103 · Cited by 497
Kim, J. E., & Chen, J. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2748 · Cited by 454
Staels, B., Rubenstrunk, A., Noel, B., Rigou, G., Delataille, P., Millatt, L. J., Baron, M., Lucas, A., Tailleux, A., Hum, D. W., et al. (2013) · Hepatology · doi:10.1002/hep.26461 · Cited by 414
Self-citationStaels, B., Vu-Dac, N., Kosykh, V. A., Saladin, R., Fruchart, J. C., Dallongeville, J., & Auwerx, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117717 · Cited by 410
Self-citationVu-Dac, N., Schoonjans, K., Kosykh, V, Dallongeville, J., Fruchart, J. C., Staels, B., & Auwerx, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118118 · Cited by 397
Self-citationMorán‐Salvador, E., López‐Parra, M., García‐Alonso, V., Titos, E., Martínez‐Clemente, M., González‐Périz, A., López‐Vicario, C., Barak, Y., Arroyo, V., & Clària, J. (2011) · The FASEB Journal · doi:10.1096/fj.10-173716 · Cited by 389
Oberbach, A., Bossenz, Y., Lehmann, S., Niebauer, J., Adams, V., Paschke, R., Schön, M. R., Blüher, M., & Punkt, K. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1854 · Cited by 385
Ip, E., Farrell, G., Hall, P., Robertson, G., & Leclercq, I. (2004) · Hepatology · doi:10.1002/hep.20170 · Cited by 383
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., Min, J., Spann, N. J., McDonald, J. G., Kelly, S. L., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p056002 · Cited by 372
Schuler, M., Ali, F., Chambon, C., Duteil, D., Bornert, J.-M., Tardivel, A., Desvergne, B., Wahli, W., Chambon, P., & Metzger, D. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.003 · Cited by 367
Francque, S., Verrijken, A., Caron, S., Prawitt, J., Paumelle, R., Derudas, B., Lefebvre, P., Taskinen, M.-R., Van Hul, W., Mertens, I., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.019 · Cited by 357
Self-citationFan, C.-Y., Pan, J., Usuda, N., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15639 · Cited by 343
Patsouris, D., Reddy, J. K., Müller, M., & Kersten, S. (2006) · Endocrinology · doi:10.1210/en.2005-1132 · Cited by 340
Chung, S. W., Kang, B. Y., Kim, S. H., Pak, Y. K., Cho, D., Trinchieri, G., & Kim, T. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002577200 · Cited by 338
Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
Kallen, C. B., & Lazar, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5793 · Cited by 337
Le Bacquer, O., Petroulakis, E., Paglialunga, S., Poulin, F., Richard, D., Cianflone, K., & Sonenberg, N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29528 · Cited by 334
Risérus, U., Sprecher, D., Johnson, T., Olson, E., Hirschberg, S., Liu, A., Fang, Z., Hegde, P., Richards, D., Sarov-Blat, L., et al. (2008) · Diabetes · doi:10.2337/db07-1318 · Cited by 325
Depletion of fat-resident Treg cells prevents age-associated insulin resistance
Bapat, S. P., Myoung Suh, J., Fang, S., Liu, S., Zhang, Y., Cheng, A., Zhou, C., Liang, Y., LeBlanc, M., Liddle, C., et al. (2015) · Nature · doi:10.1038/nature16151 · Cited by 324
Zhang, H., Zhang, A., Kohan, D. E., Nelson, R. D., Gonzalez, F. J., & Yang, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501744102 · Cited by 317
Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone
Sakamoto, J., Kimura, H., Moriyama, S., Odaka, H., Momose, Y., Sugiyama, Y., & Sawada, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3868 · Cited by 313
An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
Banks, A. S., McAllister, F. E., Camporez, J. P. G., Zushin, P.-J. H., Jurczak, M. J., Laznik-Bogoslavski, D., Shulman, G. I., Gygi, S. P., & Spiegelman, B. M. (2015) · Nature · doi:10.1038/nature13887 · Cited by 297
A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis
Jonker, J. W., Suh, J. M., Atkins, A. R., Ahmadian, M., Li, P., Whyte, J., He, M., Juguilon, H., Yin, Y.-Q., Phillips, C. T., et al. (2012) · Nature · doi:10.1038/nature10998 · Cited by 280
The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting
Longuet, C., Sinclair, E. M., Maida, A., Baggio, L. L., Maziarz, M., Charron, M. J., & Drucker, D. J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.008 · Cited by 272
Madsen, M. S., Siersbæk, R., Boergesen, M., Nielsen, R., & Mandrup, S. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01344-13 · Cited by 272
Hepatic peroxisome proliferation in rodents and its significance for humans
Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., & Wiegand, H.-J. (1993) · Food and Chemical Toxicology · doi:10.1016/0278-6915(93)90225-n · Cited by 271
Angela, M., Endo, Y., Asou, H. K., Yamamoto, T., Tumes, D. J., Tokuyama, H., Yokote, K., & Nakayama, T. (2016) · Nature Communications · doi:10.1038/ncomms13683 · Cited by 259
A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease
Fernández-Miranda, C., Pérez-Carreras, M., Colina, F., López-Alonso, G., Vargas, C., & Solís-Herruzo, J. A. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.002 · Cited by 256
Garcia-Roves, P., Huss, J. M., Han, D.-H., Hancock, C. R., Iglesias-Gutierrez, E., Chen, M., & Holloszy, J. O. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704024104 · Cited by 246
Lu, M., Sarruf, D. A., Talukdar, S., Sharma, S., Li, P., Bandyopadhyay, G., Nalbandian, S., Fan, W., Gayen, J. R., Mahata, S. K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2332 · Cited by 227
Prospective functional classification of all possible missense variants in PPARG
UK Monogenic Diabetes Consortium, Majithia, A. R., Myocardial Infarction Genetics Consortium, UK Congenital Lipodystrophy Consortium, Tsuda, B., Agostini, M., Gnanapradeepan, K., Rice, R., Peloso, G., Patel, K. A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3700 · Cited by 227
Muoio, D. M., Way, J. M., Tanner, C. J., Winegar, D. A., Kliewer, S. A., Houmard, J. A., Kraus, W. E., & Dohm, G. L. (2002) · Diabetes · doi:10.2337/diabetes.51.4.901 · Cited by 225
Watts, G. F., Barrett, P. H. R., Ji, J., Serone, A. P., Chan, D. C., Croft, K. D., Loehrer, F., & Johnson, A. G. (2003) · Diabetes · doi:10.2337/diabetes.52.3.803 · Cited by 219
Goto, T., Lee, J.-Y., Teraminami, A., Kim, Y.-I., Hirai, S., Uemura, T., Inoue, H., Takahashi, N., & Kawada, T. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011320 · Cited by 217
Cariou, B., Hanf, R., Lambert-Porcheron, S., Zaïr, Y., Sauvinet, V., Noël, B., Flet, L., Vidal, H., Staels, B., & Laville, M. (2013) · Diabetes Care · doi:10.2337/dc12-2012 · Cited by 215
Self-citationIshibashi, S., Yamashita, S., Arai, H., Araki, E., Yokote, K., Suganami, H., Fruchart, J.-C., & Kodama, T. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.029 · Cited by 208 · cited 2×
“Pemafibrate (K-877) Improved lipid profile in patients with dyslipidemia (175) Phase 3 CV outcome trial ongoing for treatment of dyslipidemia”
Lefterova, M. I., Steger, D. J., Zhuo, D., Qatanani, M., Mullican, S. E., Tuteja, G., Manduchi, E., Grant, G. R., & Lazar, M. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01651-09 · Cited by 207
Brain fatty acid synthase activates PPARα to maintain energy homeostasis
Chakravarthy, M. V., Zhu, Y., López, M., Yin, L., Wozniak, D. F., Coleman, T., Hu, Z., Wolfgang, M., Vidal-Puig, A., Lane, M. D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31183 · Cited by 207
Vu-Dac, N., Gervois, P., Jakel, H., Nowak, M., Baugé, E., Dehondt, H., Staels, B., Pennacchio, L. A., Rubin, E. M., Fruchart-Najib, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212191200 · Cited by 206
Self-citationHuman Muscle Fiber Type–Specific Insulin Signaling: Impact of Obesity and Type 2 Diabetes
Albers, P. H., Pedersen, A. J. T., Birk, J. B., Kristensen, D. E., Vind, B. F., Baba, O., Nøhr, J., Højlund, K., & Wojtaszewski, J. F. P. (2015) · Diabetes · doi:10.2337/db14-0590 · Cited by 204
Vernia, S., Cavanagh-Kyros, J., Garcia-Haro, L., Sabio, G., Barrett, T., Jung, D. Y., Kim, J. K., Xu, J., Shulha, H. P., Garber, M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.010 · Cited by 199
Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism
Gan, Z., Rumsey, J., Hazen, B. C., Lai, L., Leone, T. C., Vega, R. B., Xie, H., Conley, K. E., Auwerx, J., Smith, S. R., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67652 · Cited by 198
Regulation of lipid metabolism by angiopoietin-like proteins
Dijk, W., & Kersten, S. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000290 · Cited by 192
A role for PPARα in the control of SREBP activity and lipid synthesis in the liver
Knight, B. L., Hebbachi, A., Hauton, D., Brown, A.-M., Wiggins, D., Patel, D. D., & Gibbons, G. F. (2005) · Biochemical Journal · doi:10.1042/bj20041896 · Cited by 188
Cipolletta, D., Cohen, P., Spiegelman, B. M., Benoist, C., & Mathis, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423486112 · Cited by 186
van der Veen, J. N., Kruit, J. K., Havinga, R., Baller, J. F. W., Chimini, G., Lestavel, S., Staels, B., Groot, P. H. E., Groen, A. K., & Kuipers, F. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400400-jlr200 · Cited by 186
Self-citationSahebkar, A., Chew, G. T., & Watts, G. F. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.876992 · Cited by 180
Deeg, M. A., Buse, J. B., Goldberg, R. B., Kendall, D. M., Zagar, A. J., Jacober, S. J., Khan, M. A., Perez, A. T., Tan, M. H., & on behalf of the GLAI Study Investigators (2007) · Diabetes Care · doi:10.2337/dc06-1903 · Cited by 179
Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
Liu, S., Hatano, B., Zhao, M., Yen, C.-C., Kang, K., Reilly, S. M., Gangl, M. R., Görgün, C. Z., Balschi, J. A., Ntambi, J. M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.138115 · Cited by 176
Cariou, B., Zaïr, Y., Staels, B., & Bruckert, E. (2011) · Diabetes Care · doi:10.2337/dc11-0093 · Cited by 172
Self-citationLoyer, X., Paradis, V., Hénique, C., Vion, A.-C., Colnot, N., Guerin, C. L., Devue, C., On, S., Scetbun, J., Romain, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308883 · Cited by 171
Self-citationMajithia, A. R., Flannick, J., Shahinian, P., Guo, M., Bray, M.-A., Fontanillas, P., Gabriel, S. B., GoT2D Consortium, NHGRI JHS/FHS Allelic Spectrum Project, SIGMA T2D Consortium, et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410428111 · Cited by 171
Minireview: Challenges and Opportunities in Development of PPAR Agonists
Wright, M. B., Bortolini, M., Tadayyon, M., & Bopst, M. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1427 · Cited by 168
Shao, M., Shan, B., Liu, Y., Deng, Y., Cheng, Y., Wu, Y., Mao, T., Qiu, Y., Zhou, Y., Jiang, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4528 · Cited by 166
Barroso, E., Rodríguez-Calvo, R., Serrano-Marco, L., Astudillo, A. M., Balsinde, J., Palomer, X., & Vázquez-Carrera, M. (2011) · Endocrinology · doi:10.1210/en.2010-1468 · Cited by 161
Fibrates and future PPARα agonists in the treatment of cardiovascular disease
Staels, B., Maes, M., & Zambon, A. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1278 · Cited by 160
Self-citationMurakami, M., Tognini, P., Liu, Y., Eckel‐Mahan, K. L., Baldi, P., & Sassone‐Corsi, P. (2016) · EMBO reports · doi:10.15252/embr.201642463 · Cited by 158
Bays, H. E., Schwartz, S. L., Littlejohn, T. W., Kerzner, B., Krauss, R. M., Karpf, D. B., Choi, Y., Wang, X., Naim, S., & Roberts, B. K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1061 · Cited by 157
Transcriptional Regulatory Circuits Controlling Brown Fat Development and Activation
Seale, P. (2015) · Diabetes · doi:10.2337/db15-0203 · Cited by 154
Disturbances in the normal regulation of SREBP-sensitive genes in PPARα-deficient mice
Patel, D., Knight, B. L., Wiggins, D. K., Humphreys, S. M., & Gibbons, G. F. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31655-2 · Cited by 153
Zheng, L., Lv, G., Sheng, J., & Yang, Y. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05949.x · Cited by 151
Regulation of Steatohepatitis and PPARγ Signaling by Distinct AP-1 Dimers
Hasenfuss, S. C., Bakiri, L., Thomsen, M. K., Williams, E. G., Auwerx, J. H., & Wagner, E. F. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.018 · Cited by 143
Pawlak, M., Baugé, E., Bourguet, W., De Bosscher, K., Lalloyer, F., Tailleux, A., Lebherz, C., Lefebvre, P., & Staels, B. (2014) · Hepatology · doi:10.1002/hep.27297 · Cited by 141
Self-citationSkogsberg, J., Kannisto, K., Cassel, T. N., Hamsten, A., Eriksson, P. O., & Ehrenborg, E. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064383.88696.24 · Cited by 139
Hennuyer, N., Duplan, I., Paquet, C., Vanhoutte, J., Woitrain, E., Touche, V., Colin, S., Vallez, E., Lestavel, S., Lefebvre, P., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.003 · Cited by 132 · cited 2×
“The selective PPAR α agonist pemafibrate (K-877) (174) exhibited greater lipid modifying efficacy than fenofibrate in a phase 2 trial, with little or no effect on serum creatinine and homocysteine levels (175).”
Self-citationLalloyer, F., Vandewalle, B., Percevault, F., Torpier, G., Kerr-Conte, J. A., Oosterveer, M. H., Paumelle, R., Fruchart, J., Kuipers, F., Pattou, F. N., et al. (2006) · Diabetes · doi:10.2337/db06-0016 · Cited by 131
Self-citationJani, R. H., Pai, V., Jha, P. R., Jariwala, G., Mukhopadhyay, S., Bhansali, A. K., & Joshi, S. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0253 · Cited by 120
Roberts, L. D., Murray, A. J., Menassa, D. A., Ashmore, T., Nicholls, A. W., & Griffin, J. L. (2011) · Genome biology · doi:10.1186/gb-2011-12-8-r75 · Cited by 120
Tang, T., Abbott, M. J., Ahmadian, M., Lopes, A. B., Wang, Y., & Sul, H. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.012 · Cited by 119
Pai, V., Paneerselvam, A., Mukhopadhyay, S., Bhansali, A. K., Kamath, D., Shankar, V., Gambhire, D., Jani, R. H., Joshi, S., & Patel, P. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813518680 · Cited by 119
So, W. Y., Cheng, Q., Chen, L., Evans‐Molina, C., Xu, A., Lam, K. S. L., & Leung, P. S. (2013) · Diabetes · doi:10.2337/db13-0645 · Cited by 119
Siersbæk, M. S., Loft, A., Aagaard, M. M., Nielsen, R., Schmidt, S. F., Petrovič, N., Nedergaard, J., & Mandrup, S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00526-12 · Cited by 119
Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo
Soccio, R. E., Chen, E. R., Rajapurkar, S. R., Safabakhsh, P., Marinis, J. M., Dispirito, J. R., Emmett, M. J., Briggs, E. R., Fang, B., Everett, L. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.025 · Cited by 117
Bougarne, N., Paumelle, R., Caron, S., Hennuyer, N., Mansouri, R. M., Gervois, P. P., Staels, B., Haegeman, G., & Bosscher, K. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806742106 · Cited by 117
Self-citationRole of PPAR in Hepatic Carbohydrate Metabolism
Peeters, A., & Baes, M. I. (2010) · PPAR Research · doi:10.1155/2010/572405 · Cited by 110
Vrins, C. L. J., van der Velde, A. E., van den Oever, K., Levels, J. H. M., Huet, S., Elferink, R. P. J. O., Kuipers, F., & Groen, A. K. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800579-jlr200 · Cited by 104
Dubois‐Chevalier, J., Oger, F., Dehondt, H., Firmin, F. F., Gheeraert, C., Staels, B., Lefèbvre, P., & Eeckhoute, J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku780 · Cited by 103
Self-citationPan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
Ruzehaji, N., Frantz, C., Ponsoye, M., Avouac, J., Pezet, S., Guilbert, T., Luccarini, J., Broqua, P., Junien, J., & Allanore, Y. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208029 · Cited by 103
Jha, P., Claudel, T., Baghdasaryan, A., Mueller, M., Halilbasic, E., Das, S. K., Lass, A., Zimmermann, R., Zechner, R., Höefler, G., et al. (2013) · Hepatology · doi:10.1002/hep.26732 · Cited by 102
Choi, S., Kim, E. S., Jung, J., Marciano, D. P., Jo, A., Koo, J. Y., Choi, S. Y., Yang, Y. R., Jang, H., Kim, E., et al. (2016) · Diabetes · doi:10.2337/db15-1382 · Cited by 101
Bouly, M., Masson, D., Gross, B. S., Jiang, X., Fiévet, C., Castro, G. R., Tall, A. R., Fruchart, J., Staels, B., Lagrost, L., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101160200 · Cited by 99
Self-citationMarino, J. S., Stechschulte, L. A., Stec, D. E., Nestor‐Kalinoski, A. L., Coleman, S., & Hinds, T. D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752311 · Cited by 94
Woller, A., Duez, H., Staels, B., & Lefranc, M. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.060 · Cited by 92
Self-citationThe impact of PPARα activation on whole genome gene expression in human precision cut liver slices
Janssen, A. W. F., Betzel, B., Stoopen, G. M., Berends, F. J., Janssen, I. M. C., Peijnenburg, A., & Kersten, S. (2015) · BMC Genomics · doi:10.1186/s12864-015-1969-3 · Cited by 90
Role of Adiponectin in Coronary Heart Disease Risk: A Mendelian Randomization Study
Borges, M. C., Lawlor, D. A., de Oliveira, C. M., White, J., Horta, B. L., & Barros, A. J. D. (2016) · Circulation Research · doi:10.1161/circresaha.116.308716 · Cited by 89
Gachon, F., Leuenberger, N., Claudel, T., Gos, P., Jouffe, C., Fleury-Olela, F., du Jeu, X. D. M., Wahli, W., & Schibler, U. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002862108 · Cited by 88
Choi, S., Kim, E. S., Koh, M., Lee, S., Lim, D., Yang, Y. R., Jang, H., Seo, K., Min, S., Lee, I. H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566794 · Cited by 87
Dunn, F. L., Higgins, L. S., Fredrickson, J. O., & DePaoli, A. M. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.06.006 · Cited by 87
Flavell, D. M., Ireland, H., Stephens, J. W., Hawe, E., Acharya, J., Mather, H. M., Hurel, S. J., & Humphries, S. E. (2005) · Diabetes · doi:10.2337/diabetes.54.2.582 · Cited by 83
Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice
Greenstein, A. W., Majumdar, N., Yang, P., Subbaiah, P. V., Kineman, R. D., & Córdoba‐Chacón, J. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0447 · Cited by 82
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia
Choi, Y., Roberts, B. K., Wang, X., Geaney, J. C., Naim, S., Wojnoonski, K., Karpf, D. B., & Krauss, R. M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.029 · Cited by 80
The Interleukin-1 receptor antagonist is a direct target gene of PPARα in liver
Stienstra, R., Mandard, S., Tan, N. S., Wahli, W., Trautwein, C., Richardson, T. A., Lichtenauer-Kaligis, E. G. R., Kersten, S., & Müller, M. M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.11.019 · Cited by 80
Schreiber, R., Hofer, P., Taschler, U., Voshol, P. J., Rechberger, G. N., Kotzbeck, P., Jaeger, D., Preiss-Landl, K., Lord, C. C., Brown, J. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516004112 · Cited by 79
PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
Daoudi, M., Hennuyer, N., Borland, M. G., Touche, V., Duhem, C., Gross, B. S., Caiazzo, R. J., Kerr-Conte, J. A., Pattou, F. N., Peters, J. M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.045 · Cited by 79
Self-citationBojic, L. A., Telford, D. E., Fullerton, M. D., Ford, R. J., Sutherland, B. G., Edwards, J. Y., Sawyez, C. G., Gros, R., Kemp, B. E., Steinberg, G. R., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m046037 · Cited by 78
Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARα
Ratman, D., Mylka, V., Bougarne, N., Pawlak, M., Caron, S., Hennuyer, N., Paumelle, R., Cauwer, L. D., Thommis, J., Rider, M. H., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw742 · Cited by 77
Self-citationCREBH Couples Circadian Clock With Hepatic Lipid Metabolism
Zheng, Z., Kim, H., Qiu, Y., Chen, X., Méndez, R., Dandekar, A. P., Zhang, X., Zhang, C., Liu, A. C., Yin, L., et al. (2016) · Diabetes · doi:10.2337/db16-0298 · Cited by 77
Colin, S., Briand, O., Touche, V., Wouters, K., Baron, M., Pattou, F. N., Hanf, R., Tailleux, A., Chinetti, G., Staels, B., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs227 · Cited by 74
Self-citationThrap3 docks on phosphoserine 273 of PPARγ and controls diabetic gene programmingPreprint
Choi, J. H., Choi, S., Kim, E. S., Jedrychowski, M. P., Yang, Y. R., Jang, H., Suh, P., Banks, A. S., Gygi, S. P., & Spiegelman, B. M. (2014) · Genes & Development · doi:10.1101/gad.249367.114 · Cited by 69
Rosenson, R. S., Wright, R. S., Farkouh, M. E., & Plutzky, J. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.06.023 · Cited by 69
Krysiak, R. G., Gdula‐Dymek, A., Bachowski, R., & Okopień, B. (2010) · Diabetes Care · doi:10.2337/dc10-0272 · Cited by 69
Andrulionytė, L., Peltola, P., Chiasson, J., Laakso, M., & for the STOP-NIDDM Study Group (2006) · Diabetes · doi:10.2337/db05-1629 · Cited by 69
Bonds, D. E., Craven, T. E., Buse, J. B., Crouse, J. R., Cuddihy, R. M., Elam, M. B., Ginsberg, H. N., Kirchner, K. A., Marcovina, S. M., Mychaleckyj, J. C., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2524-2 · Cited by 67
Meier, C. A., Chicheportiche, R., Juge-Aubry, C. E., Dreyer, M. G., & Dayer, J. (2002) · Cytokine · doi:10.1006/cyto.2002.1945 · Cited by 66
Molecular Architecture of Transcription Factor Hotspots in Early Adipogenesis
Siersbæk, R., Baek, S., Rabiee, A., Nielsen, R., Traynor, S., Clark, N., Sandelin, A., Jensen, O. N., Sung, M., Hager, G. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.043 · Cited by 65
Andrulionytė, L., Kuulasmaa, T., Chiasson, J., Laakso, M., & for the STOP-NIDDM Study Group (2007) · Diabetes · doi:10.2337/db06-1110 · Cited by 64
Mansouri, R. M., Baugé, E., Staels, B., & Gervois, P. P. (2008) · Endocrinology · doi:10.1210/en.2007-1339 · Cited by 63
Self-citationIn VitroandIn VivoCharacterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist
He, B., Ning, Z., Li, Z. B., Shan, S., Pan, D., Ko, B. C. B., Li, P., Shen, Z., Dou, G., Zhang, B. L., et al. (2012) · PPAR Research · doi:10.1155/2012/546548 · Cited by 61
Vänttinen, M., Nuutila, P., Kuulasmaa, T., Pihlajamäki, J., Hällsten, K., Virtanen, K. A., Läutamaki, R., Peltoniemi, P., Takala, T., Viljanen, A. P. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3587 · Cited by 57
Massaro, M., Scoditti, E., Pellegrino, M., Carluccio, M. A., Calabriso, N., Wabitsch, M., Storelli, C., Wright, M. B., & Caterina, R. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.027 · Cited by 56
Mogilenko, D. A., Кудрявцев, И. В., Shavva, V. S., Dizhe, E. B., Виленская, Е. Г., Efremov, A. M., Ap, P., & Orlov, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437525 · Cited by 55
Dual Outcomes of Rosiglitazone Treatment on Fatty Liver
Gao, M., Ma, Y., Alsaggar, M., & Liu, D. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9919-9 · Cited by 54
Effect of fasting on PPARγ and AMPK activity in adipocytes
Kajita, K., Mune, T., Ikeda, T., Matsumoto, M., Uno, Y., Sugiyama, C., Matsubara, K., Morita, H., Takemura, M., Seishima, M., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.05.003 · Cited by 51
PPARa‐ATGL pathway improves muscle mitochondrial metabolism: implication in aging
Biswas, D., Ghosh, M., Kumar, S., & Chakrabarti, P. (2016) · The FASEB Journal · doi:10.1096/fj.201600571rr · Cited by 46
Othman, A., Benghozi, R., Alecu, I., Yu, W., Niesor, E. J., von Eckardstein, A., & Hornemann, T. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.03.011 · Cited by 43
Oger, F., Dubois‐Chevalier, J., Gheeraert, C., Avner, S., Durand, E., Froguel, P., Salbert, G., Staels, B., Lefèbvre, P., & Eeckhoute, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.526996 · Cited by 42
Self-citationKocalis, H. E., Turney, M. K., Printz, R. L., Laryea, G. N., Muglia, L. J., Davies, S. S., Stanwood, G. D., McGuinness, O. P., & Niswender, K. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042981 · Cited by 41
Chinetti, G., & Staels, B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.009 · Cited by 40
Self-citationFenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity
Ramakrishnan, S. K., Russo, L., Ghanem, S. S., Patel, P. R., Oyarce, A. M., Heinrich, G., & Najjar, S. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.745778 · Cited by 39
Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome
Vega, G. L., Cater, N. B., Hadizadeh, D. R., Meguro, S., & Grundy, S. M. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00170-x · Cited by 36
Khera, A. V., Millar, J. S., Ruotolo, G., Wang, M.-D., & Rader, D. J. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv291 · Cited by 34
PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation
Zou, W., Rohatgi, N., Chen, T. H.-P., Schilling, J. D., Abu‐Amer, Y., & Teitelbaum, S. L. (2016) · Nature Medicine · doi:10.1038/nm.4208 · Cited by 33
Maganti, A. V., Tersey, S. A., Syed, F., Nelson, J. B., Colvin, S. C., Maier, B., & Mirmira, R. G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.741694 · Cited by 31
PPAR-β/δ activation promotes phospholipid transfer protein expression
Chehaibi, K., Cedó, L., Metso, J., Palomer, X., Santos, D., Quesada, H., Slimane, M. N., Wahli, W., Julve, J., Vázquez‐Carrera, M., et al. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.01.016 · Cited by 30
PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation
Barroso, E., Rodríguez‐Rodríguez, R., Chacón, M. R., Maymó‐Masip, E., Ferrer‐Font, L., Salvadó, L., Salmerón, E., Wabistch, M., Palomer, X., Vendrell, J. J., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.02.010 · Cited by 29
DiSpirito, J. R., Fang, B., Wang, F., & Lazar, M. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00599-13 · Cited by 29
Damiano, F., Gnoni, G. V., & Siculella, L. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.01.003 · Cited by 27
Qian, Y., Li, P., Zhang, J., Shi, Y., Chen, K., Yang, J., Wu, Y., & Ye, X. (2016) · Medicine · doi:10.1097/md.0000000000004299 · Cited by 25
Zhou, T., Yan, X., Wang, G., Liu, H., Gan, X., Zhang, T., Wang, J., & Li, L. (2015) · BioMed Research International · doi:10.1155/2015/613910 · Cited by 23
Black, N., Ennis, C. N., Young, I. S., Hunter, S. J., Atkinson, A. B., & Bell, P. M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.01.001 · Cited by 23
Fan, W., Shen, C., Wu, M., Zhou, Z.-Y., & Guo, Z. (2015) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2015.0002 · Cited by 22
Li, X., LI, J., Lu, X., Ma, H., Shi, H., Li, H., Xie, D., Dong, L., & Liang, C. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2270 · Cited by 18
Kimura, R., Takahashi, N., Goto, T., Murota, K., & Kawada, T. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.05.005 · Cited by 14
PPARδ increases expression of the human apolipoprotein A-II gene in human liver cells
Thulin, P., Glinghammar, B., Skogsberg, J., Lundell, K., & Ehrenborg, E. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.6.819 · Cited by 14
Goto, T., Nakayama, R., Yamanaka, M., Takata, M., Takazawa, T., Watanabe, K., Maruta, K., Nagata, R., Nagamine, J., Tsuchida, A., et al. (2015) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1549965 · Cited by 12
Genetic Variation and Insulin Resistance in Middle‐Aged Chinese Men
Villegas, R., Delahanty, R., Williams, S. M., Li, H., O'Brian, R., Shi, J., Cai, Q., Xiang, Y., & Shu, X. O. (2015) · Annals of Human Genetics · doi:10.1111/ahg.12124 · Cited by 2
Cited by
PPAR control of metabolism and cardiovascular functions
Montaigne, D., Butruille, L., & Staels, B. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00569-6 · Cited by 942
Self-citationMolecular Actions of PPARα in Lipid Metabolism and Inflammation
Bougarne, N., Weyers, B., Desmet, S. J., Deckers, J., Ray, D. W., Staels, B., & De Bosscher, K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00064 · Cited by 898
Self-citationThe role of peroxisome proliferator-activated receptors (PPAR) in immune responses
Christofides, A., Konstantinidou, E., Jani, C., & Boussiotis, V. A. (2021) · Metabolism · doi:10.1016/j.metabol.2020.154338 · Cited by 720
Tanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
Deprince, A., Haas, J. T., & Staels, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101092 · Cited by 554
Self-citation
Metadata
- Authors
- Dubois, V., Eeckhoute, J., Lefebvre, P., & Staels, B.
- Venue
- Journal of Clinical Investigation
- Published
- 2017-04-03
- Volume
- 127
- Issue
- 4
- Pages
- 1202-1214
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2602059628
- Cited by
- 383
- References
- 192
- FWCI
- 10.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.